Related Experiment Video
Updated: Feb 21, 2026
09:25
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
19.7K
Managing sarcoma: where have we come from and where are we going?
Jenna S Bleloch1, Reyna D Ballim1, Serah Kimani1
1Department of Human Biology, University of Cape Town, South Africa.
Therapeutic Advances in Medical Oncology
|October 5, 2017
Summary
Sarcomas are rare cancers affecting soft tissue or bone. New targeted therapies offer hope for treating these diverse and challenging tumors, especially in children and young adults.
Area of Science:
- Oncology
- Cancer Research
- Molecular Pathology
Background:
- Sarcomas are a diverse group of cancers originating from mesenchymal tissues, with over 100 subtypes identified.
- While rare in adults, sarcomas constitute a significant portion of pediatric malignancies, posing substantial risks.
- Current treatments for metastatic or unresectable sarcomas are often palliative due to limited efficacy.
Purpose of the Study:
- To review current management strategies for various sarcoma subtypes.
- To highlight emerging targeted therapies based on molecular understanding.
- To discuss novel treatments currently in clinical trials for sarcomas.
Main Methods:
- Literature review of sarcoma management.
- Analysis of current clinical trial data for novel therapies.
- Discussion of molecular pathogenesis in relation to treatment.
Main Results:
- Sarcoma heterogeneity leads to variable responses to generalized treatments.
- Targeted therapies show promise for specific sarcoma subtypes.
- Clinical trials are exploring new treatment avenues for advanced sarcomas.
Conclusions:
- There is a critical need for subtype-specific sarcoma treatments.
- Targeted therapies represent a rapidly advancing frontier in sarcoma management.
- Ongoing clinical trials are essential for developing curative strategies for metastatic and unresectable sarcomas.
Related Concept Videos
01:21Cancer Survival Analysis
793
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
793
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:07Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
02:49Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K